Amphetamine use disorder
Amphetamine Use Disorder is a type of Substance Use Disorder characterized by the misuse and overuse of amphetamines, a class of potent central nervous system stimulants.
Definition[edit | edit source]
Amphetamine Use Disorder is defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) as a pattern of amphetamine-type substance use leading to clinically significant impairment or distress. This is manifested by at least two of the following symptoms occurring within a 12-month period:
- The amphetamines are often taken in larger amounts or over a longer period than was intended.
- There is a persistent desire or unsuccessful efforts to cut down or control amphetamine use.
- A great deal of time is spent in activities necessary to obtain the amphetamine, use the amphetamine, or recover from its effects.
- Craving, or a strong desire or urge to use amphetamines.
- Recurrent amphetamine use resulting in a failure to fulfill major role obligations at work, school, or home.
- Continued amphetamine use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of amphetamines.
- Important social, occupational, or recreational activities are given up or reduced because of amphetamine use.
- Recurrent amphetamine use in situations in which it is physically hazardous.
- Amphetamine use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance.
- Tolerance, as defined by either of the following: a) A need for markedly increased amounts of amphetamines to achieve intoxication or desired effect. b) Markedly diminished effect with continued use of the same amount of an amphetamine.
- Withdrawal, as manifested by either of the following: a) The characteristic withdrawal syndrome for amphetamines (refer to Criteria A and B of the criteria set for amphetamine withdrawal). b) Amphetamines (or a closely related substance) are taken to relieve or avoid withdrawal symptoms.
Treatment[edit | edit source]
Treatment for Amphetamine Use Disorder typically involves a combination of cognitive-behavioral therapy, motivational interviewing, and other therapeutic interventions. Medications may also be used to manage withdrawal symptoms and prevent relapse.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD